ArticleTherapeutic advances in medical oncology2022

Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.

Filippo G Dall'Olio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.